Coriolus-MRL

Coriolus-MRL

Coriolus
Coriolus

Cultivation Process of Coriolus MRL

Mycology Research Laboratories Ltd.´s Coriolus versicolor, is grown on a sterilised (autoclaved) substrate under ISO 22000:2018 standards in the EU.

This cultivation process ensures the powder complies with the EU regulation 1881/2006 for contamination of pesticides and heavy metals. The cultivation system is proprietary, allowing for standardised production of Coriolus versicolor.

MRL mushrooms biomass offers a mixture of many co-operating and co-related healthful bioavailable ingredients prepared by nature itself – it is thus a truly pure natural product.

After cultivation the Coriolus versicolor is then manufactured in the Netherlands into 500 mg tablets and in various powder forms to FSSC 22000 (Version 4.1) standards.

Veterinary products are manufactured under veterinary registration number (NL217476).

Moreover, all powder presentations are produced and manufactured in accordance with both EU and UK organic standards.

EU PT Bio 05 Logo
EU NL Bio 01 Logo
EU PT Bio 05 Logo
EU pt Bio 01 Logo
EU PT Bio 05 Logo
APCER 22000 IQNet Logos
UK Organic Logo
UK Organic Logo

Chemical and Biological Properties *

Each Tablet of Coriolus-MRL contains

Coriolus versicolor - biomass powder 500 mg

Other ingredients

Microcrystalline Cellulose
Silica
Vegetable Magnesium Sterate

Coriolus-MRL-(in vitro Enzyme Activity) per 725 mg Tablet

Protein content 17.3 mg
Reducing sugars 14.8 mg
Protein-bound polysaccharide 91.5 mg
Glucose 2-oxidase activity 49.5 mU
Peroxidase activity 67.2 mU
Laccase activity 521.5 mU
Glucoamylase / glucansase activity 6.9 U
Superoxide dismutase (SOD) activity 77.1 mU
Cytochrome P-450 0.51 nmoles
Cytochrome P-450 reductase 11.9 mU
Secondary metabolites (Thrombin inhibitors) 59%